Cancer has been recognized as one of the leading causes of mortality for decades.Magnetic resonance imaging(MRI)is a powerful imaging technology that has been widely applied in tumor diagnosis.Herein,we report the syn...Cancer has been recognized as one of the leading causes of mortality for decades.Magnetic resonance imaging(MRI)is a powerful imaging technology that has been widely applied in tumor diagnosis.Herein,we report the synthesis of magnetic iron oxide nanoparticles(MIONs)functionalized with multidentate thioether polymer ligand pentaerythritol tetrakis 3-mercaptopropionate-poly(methacrylic acid)(PTMPPMAA).Cytotoxicity assessment via the CCK-8 assay confirmed the low toxicity of the nanoparticles.MRI results showed excellent negative contrast enhancement.Bio-distribution study indicated gradual excretion of the nanoparticles.These MIONs@PTMP-PMAA exhibit strong negative contrast enhancement and present great potential as T_(2)-weighted contrast agents for MRI.展开更多
基金financially supported by the International Cooperation Program of the Ministry of Science and Technology of Hubei Province(No.2023EHA069)Shenzhen Science and Technology Program(No.JCYJ20230807143702005)+1 种基金National Foreign Experts Program(No.G2022027015L)the National Natural Science Foundation of China(No.82302265).
文摘Cancer has been recognized as one of the leading causes of mortality for decades.Magnetic resonance imaging(MRI)is a powerful imaging technology that has been widely applied in tumor diagnosis.Herein,we report the synthesis of magnetic iron oxide nanoparticles(MIONs)functionalized with multidentate thioether polymer ligand pentaerythritol tetrakis 3-mercaptopropionate-poly(methacrylic acid)(PTMPPMAA).Cytotoxicity assessment via the CCK-8 assay confirmed the low toxicity of the nanoparticles.MRI results showed excellent negative contrast enhancement.Bio-distribution study indicated gradual excretion of the nanoparticles.These MIONs@PTMP-PMAA exhibit strong negative contrast enhancement and present great potential as T_(2)-weighted contrast agents for MRI.
